Stockreport

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID [Yahoo! Finance]

Virios Therapeutics, Inc.  (VIRI) 
PDF Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses reactivation - Published data indicates increased Epstein-Barr herpes virus i [Read more]